Star Source Multi Trade Share Price | Star Source Multi Trade Stock Screener
STARSOURCE
Pharmaceuticals
Share Price BSE
₹120.00
▲
5.00 (4.35%)
As of May 21, 2026, the Star Source Multi Trade share price (BSE: STARSOURCE) is ₹120.00, up 4.35% from the previous close, with shares trading between ₹110.00 and ₹120.00, and a 52-week range of ₹75.00–₹145.75.
Check Star Source Multi Trade yearly highs lows for the annual price range and momentum.
Use the Star Source Multi Trade stock screener below to analyse P/E ratio, market cap, quarterly results, and more. Record your trades in TickJournal's free trading journal and track your portfolio performance.
Star Source Multi Trade Market Cap
₹18.04 Cr.
STARSOURCE P/E Ratio (TTM)
-
Star Source Multi Trade P/B Ratio
12.00
EPS (TTM)
₹-9.66
Dividend Yield
-
Debt to Equity
-
STARSOURCE 52 Week High
₹145.75
Star Source Multi Trade 52 Week Low
₹75.00
Operating Margin
-
Profit Margin
-
STARSOURCE Revenue (TTM)
-
EBITDA
-
Net Income
-
Total Assets
₹4.00
Total Equity
₹4.00
Star Source Multi Trade Share Price Chart
Screen Star Source Multi Trade share price with an interactive chart. Analyse STARSOURCE price trends and volatility across different timeframes.
Star Source Multi Trade Company Profile - Fundamental Screener
Screen Star Source Multi Trade company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics
for STARSOURCE shares.
Sector
Healthcare
Industry
Pharmaceuticals
Sub-Sector
Pharmaceuticals
Segment
E
ISIN
INE320M01019
Star Source Multi Trade Balance Sheet Screener
Screen STARSOURCE balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation
metrics.
| Item | 2016 |
|---|---|
| Assets | |
| Total Assets | 4 |
| Current Assets | 2 |
| Fixed Assets | 0 |
| Liabilities | |
| Total Liabilities | 0 |
| Current Liabilities | 0 |
| Non-Current Liabilities | 0 |
| Shareholders' Equity | |
| Total Equity | 4 |
| Share Capital | 2 |
| Reserves & Surplus | 2 |
Star Source Multi Trade Income Statement Screener - Profit & Revenue Analysis
Screen Star Source Multi Trade income statement and profit fundamentals.
Analyze STARSOURCE quarterly results,
revenue growth, EBITDA, net profit margins, and EPS using TickJournal's fundamental screener for Star Source Multi Trade share price evaluation.
| Item | None-None | 2016-March |
|---|---|---|
| Revenue | 0 | -1 |
| Expenses | 0 | 0 |
| EBITDA | 0 | -1 |
| Operating Profit % | 0.00% | 0.00% |
| Depreciation | 0 | 0 |
| Interest | 0 | 0 |
| Profit Before Tax | 0 | -1 |
| Tax | 0 | 0 |
| Net Profit | 0 | -1 |
| EPS | 0.00 | -9.66 |
Star Source Multi Trade Cash Flow Screener - Liquidity Fundamentals
Screen STARSOURCE cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price
strength assessment.
| Item | 2016-March |
|---|---|
| Operating Activities | -2 |
| Investing Activities | 2 |
| Financing Activities | 0 |
| Net Cash Flow | 0 |
Star Source Multi Trade Shareholding Pattern Screener
See Star Source Multi Trade shareholding pattern with promoter, FII, and DII holdings.
Check Star Source Multi Trade promoter holding and ownership changes for STARSOURCE on TickJournal.
| Item | 2026-Mar | 2025-Mar | 2025-Jun | 2025-Sept | 2025-Dec | 2024-Mar | 2024-Jun | 2024-Sept |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 27.89% | 27.89% | 27.89% | 27.89% | 27.89% | 27.89% | 27.89% | 27.89% |
| FII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| DII Holding | 0.37% | 0.37% | 0.37% | 0.37% | 0.37% | 0.37% | 0.37% | 0.37% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 65.82% | 65.29% | 65.77% | 65.66% | 65.69% | 65.61% | 65.63% | 65.60% |
| Other Holding | 5.93% | 6.46% | 5.98% | 6.09% | 6.06% | 6.14% | 6.12% | 6.15% |
| Shareholder Count | 6,292 | 6,510 | 6,422 | 6,409 | 6,360 | 6,262 | 6,254 | 6,382 |
Star Source Multi Trade Share Dividend Screener - Share Yield Analysis
Check Star Source Multi Trade dividend history with payout and yield data.
View Star Source Multi Trade dividend details including ex-dates and amounts for STARSOURCE stock.
Star Source Multi Trade Stock Index Membership
See which indices include Star Source Multi Trade stock.
Check STARSOURCE index membership in NIFTY 50, SENSEX, and other indices on TickJournal.
Star Source Multi Trade Market Events Screener - Corporate Actions
Get Star Source Multi Trade corporate actions including splits, bonuses, and buybacks.
Check Star Source Multi Trade stock events that may affect STARSOURCE share price.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| Annual General Meeting | NA | -13.88% | ||
| Annual General Meeting | NA | -5.56% | ||
| Change Of Name | NA | 0.00% | ||
| 2026-02-12 | 2026-02-12 | Quarterly Result Announcement | NA | -3.50% |
| 2025-11-13 | 2025-11-13 | Quarterly Result Announcement | NA | 7.76% |
| 2025-08-12 | 2025-08-12 | Quarterly Result Announcement | NA | 11.63% |
| 2025-05-29 | 2025-05-29 | Quarterly Result Announcement | NA | 18.64% |
| 2025-01-27 | 2025-01-27 | Quarterly Result Announcement | NA | -12.17% |
| 2024-10-28 | 2024-10-28 | Quarterly Result Announcement | NA | -7.07% |
Star Source Multi Trade Competitors Screener - Peer Comparison
Screen STARSOURCE competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better
stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical | 457,265 | 41.18 | 54,729 | 9.71% | 10,980 | 67.81 |
| Divis Laboratories | 181,448 | 72.40 | 9,712 | 18.67% | 2,191 | 66.76 |
| Torrent Pharmaceuticals | 148,703 | 65.64 | 11,539 | 6.99% | 1,911 | 57.60 |
| Cipla | 115,206 | 29.94 | 27,712 | -2.46% | 3,783 | 68.41 |
| Dr Reddys Laboratories | 111,108 | 26.84 | 33,593 | -0.44% | 3,998 | 58.65 |
| Mankind Pharma | 103,024 | 57.32 | 12,744 | 20.90% | 2,007 | 72.21 |
| Lupin | 102,944 | 19.41 | 27,488 | 19.98% | 5,345 | 43.67 |
| Zydus Life Science | 99,728 | 20.25 | 23,511 | 18.55% | 4,615 | 63.02 |
| Aurobindo Pharma | 87,149 | 25.19 | 32,346 | 9.43% | 3,484 | 69.63 |
| Laurus Labs | 71,655 | 80.32 | 6,813 | 21.03% | 884 | 80.55 |
Star Source Multi Trade Company Announcements - News Screener
Screen STARSOURCE latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2026-04-15 | Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A | - |
| 2026-04-15 | Compliances-Reg.24(A)-Annual Secretarial Compliance | - |
| 2026-04-06 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | - |
| 2026-04-01 | Reply To Clarification On Price Movement Sought By BSE Limited | - |
| 2026-03-30 | Clarification sought from Star Source Multi Trade Ltd | - |
| 2026-03-30 | Closure of Trading Window | - |
| 2026-02-16 | Revised Outcome Of Board Meeting Held On February 12 2026 | - |
| 2026-02-13 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-02-12 | Results For The Quarter And Nine Months Ended December 31 2025 | - |
| 2026-02-12 | Board Meeting Outcome for Outcome Of Board Meeting For Unaudited Financial Results For The Quarter And Nine Months Ended December 31 2025 | - |
| 2026-02-09 | Board Meeting Intimation for Considering And Approve The Un-Audited Financial Results For The Quarter And Nine Months Ended December 31 2025 Along With The Limited Review Report Thereon. | - |
| 2026-01-12 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | - |
| 2026-01-06 | Declaration Of Non-Applicability Of Regulation 23(9) Of SEBI (LODR) Regulation 2015 | - |
| 2026-01-05 | Change In Domain Name Of Website Of The Company | - |
| 2025-12-28 | Closure of Trading Window | - |
| 2025-12-26 | Announcement under Regulation 30 (LODR)-Change in Management | - |
| 2025-12-12 | Intimation Of Receipt Of No-Objection Letter For Reclassification Of Promoter(S) /Promoter Group Under Regulation 31A Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 | - |
| 2025-12-03 | Intimation Of Receipt Of Request For Reclassification From Promoter Group Shareholder To Public Shareholder Under Regulation 31A Of The SEBI (LODR) Regulations 2015 | - |
| 2025-11-14 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2025-11-13 | Results For The Quarter And Half Year Ended September 30 2025 | - |